Skip to main content

Table 3 Data Analysis Methods in Sample RCTs (N = 104)a

From: Intention-to-treat and transparency of related practices in randomized, controlled trials of anti-infectives

Primary approach described in methods, no. (%)

Results

mITT

42 (40)

ITT

38 (37)

Not stated or unclear

17 (16)

PP

4 (4)

Both mITT and PP

2 (2)

Both ITT and PP

1 (1)

Primary or secondary approach described in methods, no. (%)b

 mITT

53 (51)

 ITT

53 (50)

 PP

37 (35)

Primary approach used in results, no. (%)

 mITT

51 (49)

 ITT

34 (33)

 Not stated or unclear

10 (10)

 PP

5 (5)

 Both mITT and PP

2 (2)

 Both ITT and PP

2 (2)

  1. aITT intention-to-treat, mITT mITT, PP per protocol
  2. bNot exclusive